Most sore throats are viral and resolve without antibiotics, but distinguishing a viral sore throat from group A streptococcal pharyngitis by symptoms alone is unreliable. The Centor score, later extended by McIsaac to include children, gives clinicians a quick, structured way to estimate strep probability from four bedside findings and age — guiding who needs testing, who needs empiric treatment, and who needs neither.
How the Centor Score Was Developed
Robert Centor and colleagues published the original four-criterion rule in Medical Decision Making in 1981, derived from adult patients presenting with sore throat. Each of four findings — tonsillar exudate, tender anterior cervical lymphadenopathy, fever above 38°C, and absence of cough — contributes 1 point, producing a 0–4 point score that correlates with the probability of group A streptococcal infection.
Warren McIsaac and colleagues validated and extended the tool in JAMA in 2004, adding an age-based modifier so the score could be applied to children as young as 3, not just adults. The McIsaac modification is now the version most commonly used in primary care and urgent care settings.
Using the Score to Guide Testing and Treatment
The published probability bands rise steeply with score: roughly 1–2.5% at a score of 0 or below, up to 51–53% at a score of 4 or 5. Common practice aligned with McIsaac and IDSA guidance uses these thresholds to route patients: low scores (0–1) generally warrant no testing and no antibiotics, since a viral cause is far more likely; moderate scores (2–3) warrant rapid antigen testing or throat culture, with antibiotics given only if the test is positive; and high scores (4–5) support either test-and-treat or considering empiric antibiotic therapy, depending on local antibiotic stewardship protocols.
The goal is not to replace testing outright but to focus it — avoiding unnecessary throat swabs and antibiotics in clearly low-probability patients while still confirming the diagnosis before treating in the moderate range.
Limits and What the Score Cannot Tell You
The Centor/McIsaac score is not validated for children under age 3, a population where strep pharyngitis is uncommon and rheumatic fever risk assessment differs; the age modifier is not applied below age 3 in this calculator. The score also does not itself diagnose strep — it estimates pretest probability. A rapid antigen test or throat culture remains the diagnostic standard in most clinical settings, and local antibiotic stewardship protocols, patient risk factors (such as recent strep exposure or a history of rheumatic fever), and clinical judgment should always take precedence over the score alone.
Finally, the score was derived to identify bacterial pharyngitis specifically; it does not assess for other causes of sore throat requiring different management, such as peritonsillar abscess, epiglottitis, or infectious mononucleosis, which present with their own red-flag findings.